Stock Markets July 28, 2026 02:59 AM

Philips Says U.S. Order Delays and China Market Pressure Weighed on Q2 Results

Large, lumpy U.S. deals shifted into Q3 and China procurement changes depressed sales growth despite an upgraded full-year margin outlook

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
PHG

Philips attributed a drop in comparable order intake to the timing of several very large U.S. contracts and to market disruption in China following new centralized procurement rules, even as the company raised its full-year margin outlook after benefiting from U.S. tariff refunds. The group reported a quarterly core profit margin above analysts' expectations, but comparable orders fell 1% and shares declined.

Philips Says U.S. Order Delays and China Market Pressure Weighed on Q2 Results
PHG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Philips reported a quarterly core profit margin above analysts' expectations, aided by U.S. tariff refunds.
  • Comparable order intake fell 1% as several large U.S. orders were shifted into the third quarter - described by the CEO as a timing issue rather than a miss.
  • New centralized procurement rules in China disrupted the market for medical equipment, contributing to weaker sales growth.

Philips said delayed closings of sizable U.S. contracts and market turbulence in China weighed on its second-quarter performance, even as the company raised its margin outlook for the full year after receiving U.S. tariff refunds that helped lift quarterly profitability.

The Dutch maker of consumer electronics, home appliances and medical equipment reported a quarterly core profit margin that exceeded analysts' expectations. However, comparable order intake dropped 1% as several large orders were shifted into the third quarter, the company said.

Philips' U.S.-listed shares fell 4.4% to $25.02 on Monday, while traders indicated a 3% to 5% fall in Amsterdam-listed shares before the bell.

Addressing the timing of business wins, CEO Roy Jakobs told journalists: "That’s not a miss, but rather a timing issue." He added that some transactions are "very large in nature - multi-hundred-million or multi-million, multi-year contracts - and therefore you cannot exactly pinpoint when they will close."

Jakobs and the company highlighted China as an additional drag on second-quarter growth. Analysts at RBC also pointed to continued pressure in the Chinese market as a factor constraining Q2 sales growth.

In July, China announced a policy requiring all public medical institutions to acquire medical equipment through centralized procurement programs. Jakobs said on the press call: "We have seen that this has caused a kind of market turmoil and degrowth." He also said: "We foresee a more structurally challenging situation in China, which we had planned for."

The company framed the lower comparable order intake as a timing issue rather than an operational miss, emphasizing that the lumpy nature of some large contracts makes precise quarter-by-quarter forecasting difficult. At the same time, it acknowledged that the procurement policy change in China has created a more challenging market environment that is expected to have structural effects.


Sector impacts - The developments affect healthcare equipment and medical devices most directly, while consumer electronics and appliances are referenced as part of the broader Philips portfolio. Market reactions to the results were evident in both U.S. and Amsterdam-listed shares.

Risks

  • Timing risk from large, lumpy contracts - delayed closings can depress near-term comparable order intake and revenue recognition (affects healthcare equipment and corporate earnings).
  • Policy-driven market disruption in China - centralized procurement for public medical institutions has produced market turmoil and degrowth, creating structural challenges for sales in the region (affects medical device and healthcare markets).
  • Share price volatility - the company's U.S.-listed shares fell 4.4% and Amsterdam-listed shares were indicated to open lower, reflecting investor sensitivity to order timing and regional demand shocks (affects equity markets).

More from Stock Markets

TeamViewer Shares Slip as Customer Losses and Falling ARR Offset Higher H1 Profit Jul 28, 2026 Storytel rallies after Q2 beat and higher 2026 EBITDA target Jul 28, 2026 FTSE 100 edges higher as tech losses ease amid Middle East unrest Jul 28, 2026 European stocks steady as luxury and consumer gains offset tech selloff Jul 28, 2026 European Shares Tick Higher as Corporate Results Balance Yield Concerns Jul 28, 2026